Identification of miRNA-Mediated Subpathways as Prostate Cancer Biomarkers Based on Topological Inference in a Machine Learning Process Using Integrated Gene and miRNA Expression Data.
Source check: Source checked. Not independent scientific confirmation.
Finding: A topology-informed machine-learning process identified miRNA-mediated subpathways and candidate biomarkers distinguishing prostate-cancer groups; validation is computational and biomarker-level. External replication and prospective utility were not established in the reviewed material.
Technology: The study uses a machine-learning model for the stated identification of mirna-mediated subpathways as prostate cancer biomarkers based on topological inference in a machine learning process using integrated gene and mirna expression data task.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- The study uses a machine-learning model for the stated identification of mirna-mediated subpathways as prostate cancer biomarkers based on topological inference in a machine learning process using integrated gene and mirna expression data task.
- Test and result
- A topology-informed machine-learning process identified miRNA-mediated subpathways and candidate biomarkers distinguishing prostate-cancer groups; validation is computational and biomarker-level.
- Limitation / still unknown
- External replication, causal effects and prospective utility were not established in the reviewed material.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.3389/fgene.2021.656526
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.